JACOBIO-B (01167) announced that its subsidiary, Beijing Jacobio (an indirect non-wholly owned subsidiary), has received the first payment of RMB 125 million from Oceanpine Capital under the capital increase agreement and equity transfer agreement previously entered into among Beijing Jacobio, Jacobio Ruikang, Oceanpine Capital, and an industrial partner.
The receipt of this initial payment further strengthens the group's cash reserves and will support the advancement of its innovative oncology therapy pipeline.